Derek A. Haaland

Greater Sudbury, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up.

Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up.

Journal: PloS one

Published: September 26, 2025

Vaccination in adults at-increased risk of herpes zoster in Canada: insights from a multidisciplinary panel consensus.

Vaccination in adults at-increased risk of herpes zoster in Canada: insights from a multidisciplinary panel consensus.

Journal: Expert review of vaccines

Published: July 28, 2025

Safety of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis: Results from a Real-World Canadian Setting.

Safety of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis: Results from a Real-World Canadian Setting.

Journal: Rheumatology and therapy

Published: May 01, 2025

Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational Study.

Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational Study.

Journal: Patient preference and adherence

Published: January 24, 2025

Functional work disability from the perspectives of persons with systemic lupus erythematosus: a qualitative thematic analysis.

Functional work disability from the perspectives of persons with systemic lupus erythematosus: a qualitative thematic analysis.

Journal: Arthritis research & therapy

Published: May 17, 2024

Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.

Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.

Journal: Rheumatology and therapy

Published: December 17, 2023

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials.

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials.

Journal: International journal of rheumatic diseases

Published: January 18, 2023

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data.

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data.

Journal: Rheumatology and therapy

Published: November 13, 2022

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study.

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study.

Journal: Rheumatology and therapy

Published: August 18, 2022

Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study.

Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study.

Journal: RMD open

Published: July 22, 2021

Corrigendum to: Incidence and prevalence of giant cell arteritis in Ontario, Canada.

Corrigendum to: Incidence and prevalence of giant cell arteritis in Ontario, Canada.

Journal: Rheumatology (Oxford, England)

Published: July 05, 2020

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry.

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry.

Journal: BMC rheumatology

Published: June 01, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026